68Ga-FAPI PET/CT在肺隐球菌病及放疗后炎症中的摄取增高
一名51岁鼻咽癌治疗后男性患者,因新发肺结节行18F-FDG和68Ga-FAPI PET/CT评估肿瘤复发(前瞻性研究NCT04416165)。两种显像均显示右肺下叶结节高摄取,68Ga-FAPI另见鼻咽放疗区摄取增高;肺结节活检证实为隐球菌,鼻咽摄取因EBV稳定且随访无进展判为假阳性。
要点
- 68Ga-FAPI可在肺隐球菌等感染性病变中呈高摄取,需与肿瘤复发鉴别。
- 放疗后炎症区域可出现68Ga-FAPI假阳性摄取。
- FBV稳定且随访无进展时,鼻咽FAPI高摄取可判为假阳性。
核心结论
- 68Ga-FAPI PET/CT在肺隐球菌结节和放疗后鼻咽炎症中均可出现高摄取,可能造成假阳性。
研究设计与样本
- 前瞻性研究NCT04416165中的单例51岁鼻咽癌治疗后男性患者,因新发肺结节行18F-FDG和68Ga-FAPI PET/CT。
主要发现
- 18F-FDG和68Ga-FAPI PET/CT均显示右肺下叶结节高摄取。
- 68Ga-FAPI PET/CT另显示既往放疗的鼻咽区域摄取增高。
- CT引导活检证实肺结节为隐球菌。
- 鼻咽FAPI高摄取因EBV水平稳定且随访影像无进展判为假阳性。
临床怎么用
- 在鼻咽癌治疗后患者中,68Ga-FAPI PET/CT发现肺结节高摄取时需考虑隐球菌等感染可能。
- 对放疗区域68Ga-FAPI高摄取应结合EBV水平和随访影像鉴别假阳性。
局限性
- 为单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 51-year-old man, previously treated for nasopharyngeal carcinoma, presented a newly detected pulmonary nodule. This patient underwent 18F-FDG and 68Ga-FAPI PET/CT to detect tumor recurrence under the prospective study NCT04416165. Both 18F-FDG and 68Ga-FAPI PET/CT showed intense uptake in a pulmonary nodule in the right lower lobe. In addition, 68Ga-FAPI PET/CT demonstrated increased uptake in the nasopharynx that previously treated with radiotherapy. The pulmonary nodule was found to be cryptococcus by the CT-guided biopsy, and the increased 68Ga-FAPI uptake in the nasopharynx was interpreted as false-positive finding due to a stable Epstein-Barr virus level and no progression on follow-up imaging.
引用
- Zhao L, Pang Y, Sun L, et al. Increased 68Ga-FAPI Uptake in the Pulmonary Cryptococcus and the Postradiotherapy Inflammation. Clin Nucl Med. 2022. PMID: 34406184. doi:10.1097/RLU.0000000000003873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。